TY - CHAP A1 - Neha Dhir A2 - Ashish Jain A3 - Dhruv Mahendru A4 - Ajay Prakash A5 - Bikash Medhi ED1 - Farid A. Badria Y1 - 2020-12-02 PY - 2020 T1 - Drug Repurposing and Orphan Disease Therapeutics N2 - Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry. BT - Drug Repurposing SP - Ch. 4 UR - https://doi.org/10.5772/intechopen.91941 DO - 10.5772/intechopen.91941 SN - 978-1-83968-521-7 PB - IntechOpen CY - Rijeka Y2 - 2022-01-24 ER -